(
129
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Efficacy of dupilumab in children with uncontrolled, moderate-to-severe type 2 asthma, with/without evidence of allergic asthma: the VOYAGE phase 3 study
-
Influence of antigen density and TLR ligands on efficacy of a VLP-based vaccine against Peanut Allergy: mechanistic insights
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
Show more Event Resources (1)Show Less-
Website
Collapse
-
5.5 Years of Long-Term Efficacy of Oral Berotralstat-LTP in Hereditary Angioedema Patients
-
A pilot HRCT follow-up study to test the feasibility of predictive efficacy of serum periostin in idiopathic pulmonary fibrosis
-
A single dose of a combination of Bet v 1 antibodies provides durable efficacy in the reduction of allergic rhinitis symptoms for up to 3 months in patients with moderate-severe birch pollen allergy
-
ANCHOR-1 and 2 Study Design: Replicate Phase 3 Randomised, Double-Blind, Placebo-Controlled Studies of the Efficacy and Safety of Depemokimab in Patients with Chronic Rhinosinusitis with Nasal Polyps
-
Allergen-specific IgE/IgG4 ratio as biomarker of allergen immunotherapy efficacy in house dust mite-sensitized allergic rhinitis
-
Assessing specific pro-catabolic mediators (SPMs) as Innovative Biomarkers in Allergen Immunotherapy: Monitoring Treatment Efficacy
-
Assessment of the Efficacy of Mepolizumab in Modulating Disease Activity in Eosinophilic Granulomatosis with Polyangiitis: A 12-Month Analysis Evaluating the Birmingham Vasculitis Activity Score
-
Assessment of the Efficacy of Specific Immunotherapy After a Long Break in Asthmatic Patients
-
Biologic Agents in Neurosarcoidosis: Efficacy and Future Perspectives from a Single-Center Cohort Study
-
Biologicals for Atopic Dermatitis: Current Efficacy and Future Directions
-
Biologics for allergic diseases: efficacy and safety in a pediatric population of a tertiary hospital center
-
Bumblebee venom allergy as an emerging occupational allergy: safety and efficacy of bumblebee venom immunotherapy in a large single-center cohort
-
CHAPTER-3 Phase 3 Trial Design: Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Extended-Release Tablet for Prophylaxis of Hereditary Angioedema Attacks
-
Changes in IgG4 and IgE epitope binding profile are greater with sublingual than oral immunotherapy in milk-allergic children, and correspond to efficacy outcomes
-
Clinical Assessment of Specific Immunotherapy Efficacy in Individuals with House Dust Mite-Induced Allergic Rhinoconjunctivitis
-
Clinical characteristics of patients with hypereosinophilic syndrome and the efficacy of anti-IL-5 therapy: a retrospective cohort study
-
Clinical evaluation of the efficacy of profilin isolated from Acanthamoeba as an allergen
-
Comparable Efficacy and Pharmacodynamic Results of CT-P39 to Reference Omalizumab in Patients with Chronic Spontaneous Urticaria
-
Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria
-
Comparison of the efficacy of omalizumab and mepolizumab in non-steroidal anti-inflammatory drug-exacerbated respiratory disease
-
Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children
-
Consistent efficacy of the SQ HDM SLIT-tablet in children (5–11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis across subgroups in the MT-12 phase III trial
-
Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of tezepelumab in adult patients with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT)
-
Dissecting efficacy outcomes used in food AIT
-
Distribution of IL-1β Expression in Asthma Patients and Comparison of Therapeutic Efficacy of Different Administration Routes of IL-1β Neutralizing Antibody in a Mouse Model of Asthma
-
Dupilumab Efficacy in Allergic Bronchopulmonary Aspergillosis: a Case Report
-
Dupilumab efficacy in patients with an inadequate response, intolerance, or contraindication to swallowed topical corticosteroids: a subgroup analysis of data from the phase 3 LIBERTY EoE TREET study
-
Efficacy and safety of tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps overall and in patients with and without co-morbid asthma: results from the phase 3 WAYPOINT study
-
Efficacy Study on Intratonsillar Immunotherapy for Patients with Allergic Rhinitis Induced by House Dust Mites (Tonsil-AIT)
-
Efficacy and Safety Analysis of Omalizumab in Treating Wheat-Dependent Exercise-Induced Anaphylaxis (WDEIA) in the Chinese Population
-
Efficacy and Safety of 1-Year Dupilumab Treatment in Children Aged 6-11 years with Moderate-to-Severe Atopic Dermatitis in South Korea: Multicenter Prospective Observational Study
-
Efficacy and Safety of Chemotherapeutic Drug Desensitization in Children
-
Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Subanalysis of the Phase 3 OASIS-HAE Study
-
Efficacy and Safety of Dupilumab in Children Aged 6 Months to 5 Years With Atopic Dermatitis With and Without Type 2 Comorbidities
-
Efficacy and Safety of Hymenoptera Venom Immunotherapy
-
Efficacy and Safety of Omalizumab in Treating Severe Allergic Reactions with Urticaria as the Initial Symptom
-
Efficacy and Safety of Oral Deucrictibant, a Potent Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial
-
Efficacy and Safety of the 4-Step Egg and 5-Step Cow’s Milk Ladders in a High Risk Group of Children with IgE-mediated Food Allergy: A Case Series
-
Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design
-
Efficacy and injection schedule adjustment of Dupilumab in patients with chronic rhinosinusitis: Recent experiences in SNUH
-
Efficacy and safety of ALK 300 SRU 5-grass mix SLIT-drops in adults with grass pollen-induced rhinoconjunctivitis: results of the phase III trial RHAPSODY
-
Efficacy and safety of HDM-specific subcutaneous immunotherapy on atopic dermatitis
-
Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis
-
Efficacy and safety of Omalizumab in a Patient, previously undergoing liver transplantation, with facial angioedema, unresponsive to corticosteroids and antihistamines
-
Efficacy and safety of allergen immunotherapy in clinical practice
-
Efficacy and safety of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis (AD): a phase 2b trial (STREAM-AD)
-
Efficacy and safety of biologics in children for food allergy
-
Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR
-
Efficacy and safety of switching to bilastine, a histamine H1 receptor antagonist, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a phase IV, multicenter, open-label, randomized, parallel-group comparative controlled trial
-
Efficacy and safety of therapy with omalizumab in children with chronic spontaneous urticaria
-
Efficacy and safety profile of immunotherapy for multiple allergens in polysensitized patients with allergic rhinitis: a systematic review and meta-analysis
-
Efficacy of Benralizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) in a Real-World Setting: Experience at La Paz University Hospital
-
Efficacy of Dupilumab by Baseline Disease Severity in Children Aged 6 to 11 Years With Uncontrolled Moderate-to-Severe Asthma: Post Hoc Results From the Randomized, Placebo-Controlled VOYAGE Trial
-
Efficacy of Dupilumab in patients over 50 years of age with severe asthma
-
Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps
-
Efficacy of House Dust Mite Immunotherapy in Chinese Allergic Rhinitis Patients with Diverse Sensitization Patterns: A Multicenter Study
-
Efficacy of Omalizumab in Food Allergy Management in a Patient with Chronic Spontaneous Urticaria
-
Efficacy of Omalizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps and Association with Local Immunoglobulin E
-
Efficacy of Re-treatment with Omalizumab in Adults with Chronic Spontaneous Urticaria who Relapsed after Treatment Withdrawal
-
Efficacy of Rilzabrutinib on Asthma Control: Results From a Double-Blind Placebo-Controlled Phase 2 Study
-
Efficacy of Rilzabrutinib on Asthma Quality of Life: Results From a Double-Blind Placebo-Controlled Phase 2 Study
-
Efficacy of TAS5315, a Selective and Potent Bruton’s Tyrosine Kinase Inhibitor, in Attenuating IgE-Mediated Biphasic Cutaneous Anaphylaxis in Transgenic Mice
-
Efficacy of a sublingual bacterial extract in the production of gamma interferon and its correlation with the prevention of recurrent acute respiratory infections in pediatrics
-
Efficacy of aspirin therapy after desensitization on CRSwNP patients with N-ERD – a RDBCT study
-
Efficacy of dupilumab in atopic dermatitis with prurigo : a real-life study
-
Efficacy of lanadelumab on attack frequency and AE-QoL in Serbian patients with hereditary angioedema
-
Efficacy of two years of treatment with anti-IL-5/R therapy for reduction in use of oral glucocorticoids in patients with eosinophilic granulomatosis with polyangiitis
-
Efficacy of virus-like particle (VLP)-based immunotherapy in a mouse model of HDM allergy
-
Eosinophilic systemic diseases: clinical characterization and efficacy of anti il5/il5-r therapy in a single center italian cohort
-
Epicutaneous Immunotherapy : from mechanism to efficacy
-
Evaluation of Early Real-World Efficacy and Safety of Mepolizumab in Chronic Rhinosinusitis with Nasal Polyposis Through a Multidisciplinary Approach
-
Fixed-Dose Oral Immunotherapy for High-Threshold Food Allergy: Efficacy and Safety in Real-World Practice
-
From Efficacy to Effectiveness in Food Allergy Prevention
-
High-affinity omalizumab variants with optimized disruptive efficacy accelerate allergic effector cell desensitization
-
How different efficacy defintions impact on reported AIT trial results?
-
Impact of Switching from Omalizumab to Dupilumab in Severe Asthma Patients: A Retrospective Evaluation of Efficacy and Inflammatory Biomarkers
-
LILRA5 and CCL25 as candidate predictive biomarkers of AIT efficacy
-
Lanadelumab safety and efficacy in patients aged ≥12 with hereditary angioedema (HAE) in China for long-term prophylaxis (LTP): An open-label, multicenter study
-
Long-Term Efficacy and Safety of Remibrutinib in Patients with Chronic Spontaneous Urticaria in the Phase 3 REMIX-1 and REMIX-2 Studies
-
Long-Term Efficacy and Safety of Stapokibart in Patients with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Pivotal Phase 3 Trial
-
Long-Term Efficacy of Mepolizumab at 5 Years in Patients with Severe Asthma
-
Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study
-
Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
-
Long-term efficacy and re-sting outcomes following venom immunotherapy discontinuation: A 978-patient analysis
-
Long-term efficacy of garadacimab in patients with hereditary angioedema from the Phase 3 open-label extension study: an up to 3-year interim analysis
-
Management of Chronic Spontaneous Urticaria and Atopic Dermatitis with Omalizumab: A Case Report Highlighting Efficacy and Emerging Challenges
-
Mepolizumab Efficacy in Eosinophilic Granulomatosis with Polyangiitis with intractable middle ear effusion: a Case Report
-
Nanoparticles to improve safety and efficacy of allergen specific immunotherapy: comparison of mesoporous silica nanoparticles and cubosomes
-
Omalizumab Efficacy in Relapse of Nasal Polyposis
-
Onset of Action (OOA) and Efficacy of Azelastine Hydrochloride 0.15% Nasal Spray (AZNS) on Allergy Symptoms in an Environmental Exposure Chamber (EEC) Compared to Placebo (PL) and Mometasone Furoate/Olopatadine Hydrochloride NS (MFONS)
-
Postoperative Anti-IgE Therapy for Chronic Rhinosinusitis with Nasal Polyps and Asthma: Efficacy and Prognostic Factors
-
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
-
ROAD Study: Long-term Efficacy and Safety of Topical Therapy in Pediatric Moderate to Severe Atopic Dermatitis
-
Real-life efficacy of dupilumab in patients with asthma phenotype overlap- data from a tertiary pulmonary centre
-
Real-world efficacy of dupilumab as a second-line treatment in severe asthma- data from a tertiary pulmonary centre
-
Safety And Efficacy Of Food Ladders In Infants Presenting With Anaphylaxis
-
Safety and Efficacy of Oral Deucrictibant for Treatment of Upper Airway and Laryngeal Hereditary Angioedema Attacks: Results from the RAPIDe-2 Extension Study
-
Safety and Efficacy of VIT against Wasp Venom in Patients Older than 60 Years
-
Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients
-
Safety and efficacy of a 7-week immunotherapy protocol with aluminum hydroxide adsorbed bee venom
-
Safety and efficacy of dietary advancement therapies: a systematic review and meta-analysis
-
Study design for A multicenter, open label, randomized Study to inveStigate the effIcacy of Subcutaneous immunoTherapy combined with vitamin D3 in children and adolescent patients with allergic rhinitis (ASSIST study)
-
Study design for efficacy evaluation of subcutaneOus immunotherApy in patients with obstructive Sleep apnea concomitant with allergIc rhinitiS (OASIS study)
-
Study of Efficacy of Rush Sub Lingual Immunotherapy (RSLIT) in Cases of Severe Persistent Allergic Rhinitis
-
Subcutaneous short-course grass AIT: molecular mechanisms of humoral immune tolerance and translation into clinical efficacy
-
Subcutaneous short-course grass AIT: molecular mechanisms of humoral immune tolerance and translation into clinical efficacy
-
The Efficacy and Safety of Stepwise Oral Food Challenge in Children with Hen’s Egg Allergy
-
The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis
-
The effect of the sphenopalatine ganglion acupuncture on the clinical efficacy of cluster immunotherapy in patients with allergic rhinitis
-
The efficacy analysis and immunological changes after Alternaria alternata immunotherapy
-
The efficacy in treatment of facial melasma combined with thulium 1927-nm fractional laser and topical H2R antagonist: a split-face, single-blind study
-
The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma
-
Therapeutic efficacy of YH35324 on FcεRIα-mediated mast cell activation
-
Therapeutic efficacy of a biodegradable microneedle patch loaded with peanut allergen in a peanut allergy model
-
Topical immunosuppressants in pediatric vernal keratoconjunctivitis: evaluation of their respective efficacy in a standardized therapeutic algorithm
-
Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model
-
Twice-Yearly Depemokimab Efficacy is Sustained Across Seasons in Patients with Asthma: Analyses of Pooled Phase III SWIFT-1/2 Studies
-
Utility of basophil activation test (BAT) in evaluation of efficacy of venom immunotherapy determined by sting challenge: A systematic review
-
Validation of a novel serum-based basophil activation test (iBAT) to evaluate efficacy of a pivotal Phase III PQ Grass immunotherapy trial
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
Show more Sessions (119)Show Less-